Alteration of Clinical Chemistry Parameters Among Visceral Leishmaniasis Patients in Western Tigrai, Ethiopia, 2018/2019: A Comparative Cross-Sectional Study

References

• Leta S, Dao THT, Mesele F, Alemayehu G. Visceral leishmaniasis in Ethiopia: an evolving disease. PLoS Negl Tropica Dis. 2014;8(9):e3131. doi:10.1371/journal.pntd.0003131
   Web of Science ®Google Scholar
• Boakye D, Wilson M, Kweku M. A review of leishmaniasis in West Africa. Ghana Med J. 2005;39(3):94.17299551
   PubMedGoogle Scholar
• Palatnik-de-Sousa CB, Day MJ. One Health: the global challenge of epidemic and endemic leishmaniasis. Parasit Vectors. 2011;4(1):197. doi:10.1186/1756-3305-4-19721985335
   PubMed Web of Science ®Google Scholar
• Clementi A, Battaglia G, Floris M, Castellino P, Ronco C, Cruz DN. Renal involvement in leishmaniasis: a review of the literature. NDTPlus. 2011;4(3):147–152.
   Google Scholar
• Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. Leishmaniasis: a review. F1000Research. 2017;6.
   Google Scholar
• Mathur P, Samantaray JC, Samanta P. High prevalence of functional liver derangement in visceral leishmaniasis at an Indian tertiary care center. Clin Gastroenterol Hepatol. 2008;6(10):1170–1172. doi:10.1016/j.cgh.2008.04.03318619918
   PubMed Web of Science ®Google Scholar
• de Freitas EO, Leoratti F, Freire-de-Lima CG, Morrot A, Feijó DF. The contribution of immune evasive mechanisms to parasite persistence in visceral leishmaniasis. Front Immunol. 2016;7:153. doi:10.3389/fimmu.2016.0015327148272
   PubMed Web of Science ®Google Scholar
• Naseralla BA, Al-Quraishi MA, Jebur MS. Serological detection and liver functions of pediatric visceral leishmaniasis in Baghdad hospitals. Int J Curr Microbiol App Sci. 2015;4(1):100–107.
   Google Scholar
• Gatto M, Abreu M, Tasca KI, et al. Biochemical and nutritional evaluation of patients with visceral leishmaniasis before and after treatment with leishmanicidal drugs. Rev Soc Bras Med Trop. 2013;46(6):735–740. doi:10.1590/0037-8682-0198-201324474015
   PubMed Web of Science ®Google Scholar
• Silva Junior G, Barros EJG, Daher EDF. Kidney involvement in leishmaniasis – a review. Braz J Infect Dis. 2014;18(4):434–440. doi:10.1016/j.bjid.2013.11.01324690431
   PubMed Web of Science ®Google Scholar
• HMIS of Kahsay Abera and Mearg Hospitals. 2018.
   Google Scholar
• El Hag I, Hashim F, El Toum I, Homeida M, El Kalifa M, El Hassan A. Liver morphology and function in visceral leishmaniasis (Kala-azar). J Clin Pathol. 1994;47(6):547–551. doi:10.1136/jcp.47.6.5478063939
   PubMed Web of Science ®Google Scholar
• Kumar S, Singh R. Observation of deviations and comparisons of liver function:test in different stages of Kala-azar. IOSR J Dental Med Sci. 2018;17(7):34–40.
   Google Scholar
• Mukerrama SM, Kabir A, Deb SR, et al. Visceral Leishmaniasis turning into chronic liver disease. J Med. 2016;17(1):51–54. doi:10.3329/jom.v17i1.30063
   Google Scholar
• Prakash A, Singh N, Sridhara G, et al. Visceral leishmaniasis masquerading as chronic liver disease. J Asso Physic India. 2006;54:893–894.
   Google Scholar
• Sagnelli C, Di Martino F, Coppola N, Crisci A, Sagnelli E. Acute liver failure: a rare clinical presentation of visceral leishmaniasis. J Microbiologica Sci. 2012;35(1):93.
   Web of Science ®Google Scholar
• Dos Santos PL, de Oliveira FA, Santos MLB, et al. The severity of visceral leishmaniasis correlates with elevated levels of serum IL-6, IL-27 and sCD14. PLoS Negl Trop Dis. 2016;10(1):e0004375. doi:10.1371/journal.pntd.000437526814478
   PubMed Web of Science ®Google Scholar
• Prajapati R, Kumar A, Sharma P, et al. A rare presentation of Leishmaniasis. J Clin Exp Hepatol. 2016;6(2):146–148. doi:10.1016/j.jceh.2016.01.00127493461
   PubMedGoogle Scholar
• Çelik Ü, Leblebisatan G, Alhan E, Aksaray N. Immune hemolytic anemia in association with visceral leishmaniasis. J Pediatr Inf. 2007;1:36–38.
   Google Scholar
• Rashid AM, Al Mamun A, Rasul C, Afrafuzzaman M, Hossain M, Rahman MM. Jaundice in pediatric visceral leishmaniasis (kala-azar) patients. J Med. 2007;8(1):14–16. doi:10.3329/jom.v8i1.1374
   Google Scholar
• Bankoti R, Stäger S. Differential regulation of the immune response in the spleen and liver of mice infected with Leishmania donovani. J Tropica Med. 2012;2012.
   Google Scholar
• Kashani MN, Firooz A, Eskandari SE, et al. Evaluation of meglumine antimoniate effects on liver, kidney and pancreas function tests in patients with cutaneous leishmaniasis. Eur J Dermatol. 2007;17(6):513–515. doi:10.1684/ejd.2007.026617951131
   PubMed Web of Science ®Google Scholar
• Daher EF, Sampaio AM, Martiniano LVM, Vieira APF, Junior GBS. Acute kidney injury in visceral leishmaniasis: a cohort of 10 patients admitted to a specialized intensive care unit in northeast of Brazil. Asian Pac J Trop Dis. 2013;3(1):41–46. doi:10.1016/S2222-1808(13)60009-2
   Google Scholar
• Varma N, Naseem S. Hematologic changes in visceral leishmaniasis/kala azar. Indian J Hematol Blood Transfus. 2010;26(3):78–82. doi:10.1007/s12288-010-0027-121886387
   PubMed Web of Science ®Google Scholar
• Sulaiman SN Role of lipid profiles in visceral Leishmaniasis activity. Republic of Iraq Ministry of Higher Education and Scientific Research University of Baghdad College of Science available from:https://www.google.com/search?client=ms-opera-mini-android $oq=role+of+lipid+profile+in+visceral+leshimaniasis+activity+pdf$aqs.
   Google Scholar
• Soares NM, Leal T, Fiuza M, et al. Plasma lipoproteins in visceral leishmaniasis and their effect on Leishmania‐infected macrophages. Paras Immunol. 2010;32(4):259–266. doi:10.1111/j.1365-3024.2009.01187.x
   Web of Science ®Google Scholar
• Liberopoulos E, Alexandridis G, Bairaktari E, Elisaf M. Severe hypocholesterolemia with reduced serum lipoprotein (a) in a patient with visceral leishmaniasis. Ann Clin Lab Sci. 2002;32(3):305–308.12175095
   PubMed Web of Science ®Google Scholar
• Feingold KR, Grunfeld C. Lipids: a key player in the battle between the host and microorganisms. J Lipid Res. 2012;53(12):2487–2489. doi:10.1194/jlr.E03340723075464
   PubMed Web of Science ®Google Scholar
• Sviridov D, Bukrinsky M. Interaction of pathogens with host cholesterol metabolism. Curr Opin Lipidol. 2014;25(5):333. doi:10.1097/MOL.000000000000010625036592
   PubMed Web of Science ®Google Scholar
• Soares NM, de Souza JN, Leal TF, et al. Sera from Visceral Leishmaniasis patients display oxidative activity and affect the TNF-α production by macrophages in vitro. Bio Med Res Int. 2017. doi:10.1155/2017/5861453.
   Web of Science ®Google Scholar
• Lima FV, Lima IV, Silva GJ, Daher E, Lima EV. Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study on 50 patients from Brazil. J Nephrol. 2007;20(4):430–436.17879209
   PubMed Web of Science ®Google Scholar